SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-081568
Filing Date
2020-03-23
Accepted
2020-03-23 07:52:12
Documents
14
Period of Report
2020-03-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d881179d8k.htm   iXBRL 8-K 30250
2 EX-99.1 d881179dex991.htm EX-99.1 22410
6 GRAPHIC g881179g0321032234983.jpg GRAPHIC 6865
  Complete submission text file 0001193125-20-081568.txt   191360

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA itci-20200323.xsd EX-101.SCH 3113
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20200323_lab.xml EX-101.LAB 17375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20200323_pre.xml EX-101.PRE 10982
10 EXTRACTED XBRL INSTANCE DOCUMENT d881179d8k_htm.xml XML 3271
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 20733596
SIC: 2834 Pharmaceutical Preparations